Results 141 to 150 of about 136,189 (217)

Correction: Case Report: Fecal microbiota transplantation via capsules ameliorated clinical outcomes in a patient with multiple sclerosis. [PDF]

Front Immunol
Bibbò S, De Maio F, Capone F, Quaranta G, Rondinella D, Rosato R, Minelli M, De Lorenzis D, Sanguinetti M, Cammarota G, Di Lazzaro V, Masucci L.   +11 more
europepmc   +1 more source

Real‐world treatment trajectories preceding GLP‐1 receptor agonist initiation in type 2 diabetes: A descriptive UK population‐based cohort study on adherence to national clinical guidelines

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3692-3702, May 2026.
Abstract Aims To investigate glucose‐lowering treatment trajectories preceding glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation in UK primary care, while assessing alignment with contemporary UK clinical guidelines, considering calendar time, cardiovascular disease (CVD) history, and obesity status.
Franziska S. Ulrich, Morten Frost Nielsen, Nicola Napoli, Andrea M. Burden   +3 more
wiley   +1 more source

Perioperative management of multidrug-resistant-colonized cardiac surgery patients: are we overestimating the risk? [PDF]

Anesth Pain Med (Seoul)
Strumia A, Koulenti D, Benedetto M, Aceto J, Nenna A, Schiavoni L, Santoro S, Pascarella G, Lusini M, Barbato R, Carassiti M, Mattei A.   +11 more
europepmc   +1 more source

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4335-4343, May 2026.
ABSTRACT Background Type 1 diabetes (T1D) and overweight/obesity (OW) are chronic conditions impairing health‐related quality of life (HRQoL). While diabetes primarily affects psychosocial domains, OW impacts physical functioning and social stigma. Despite the increasing prevalence of OW among individuals with T1D, their combined effect on HRQoL has ...
Renata Risi, Domiziana Pauletto, Valeria Zanghi Buffi, Valentina Berna, Andrea Carafa, Federica Barbaro, Francesco De Vita, Luca D'Onofrio, Rocco Amendolara, Angelo Lauria Pantano, Alessandra Di Flaviani, Simona Zampetti, Dario Tuccinardi, Raffaella Buzzetti, Ernesto Maddaloni, on behalf of the AD_OWOB study group   +15 more
wiley   +1 more source

Valve-in-valve transcatheter pulmonary valve replacement in carcinoid heart disease: a case report. [PDF]

Eur Heart J Case Rep
Antonelli G, Cammalleri V, Tavernese A, Nusca A, Ussia GP.   +4 more
europepmc   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 841-855, May 2026.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Dataset of infrared absorption responses of leaves from five <i>Cannabis sativa</i> L. varieties treated with a <i>Trichoderma</i> spp.-based biomass suspension. [PDF]

Data Brief
Villamayor JDJ, Pedrozo FL, Díaz GR, Vera ML, Colmán C, Balbuena N, Sánchez V, Herrera EZ, Marsal F, Fernández D, Sotelo PH, Arrúa AA.   +11 more
europepmc   +1 more source

Efficacy of up to 4 years of tralokinumab in adults with moderate‐to‐severe atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 876-886, May 2026.
AD is a relapsing and remitting skin disease often requiring long‐term treatment. We assessed the long‐term efficacy of tralokinumab in adults with moderate‐to‐severe AD consistently treated for up to 4 years. Treatment with tralokinumab plus optional TCS/TCI provided substantial improvements in AD signs and symptoms, and these improvements were ...
Melinda Gooderham, Mahreen Ameen, H. Chih‐ho Hong, Norito Katoh, Richard G. Langley, Ketty Peris, Kristian Reich, Juan F. Silvestre, Eric Simpson, Thomas Werfel, Le Gjerum, Ann‐Marie Tindberg, Christian Bjerregård Øland, Andrew Blauvelt   +13 more
wiley   +1 more source

Characterization of a novel panel of polymorphic microsatellite loci and the mitogenome for the Neotropical marsupial Gracilinanus agilis (Didelphimorphia: Didelphidae). [PDF]

Mol Biol Rep
da Silva MRD, Lima-Rezende CA, Zangrandi PL, Mendonça AF, Caparroz R, Vieira EM, Rodrigues FP.   +6 more
europepmc   +1 more source

A Systematic Review on Applications of Artificial Intelligence for Obesity Prevention

Obesity Reviews, Volume 27, Issue 5, May 2026.
ABSTRACT This systematic review examines the applications of artificial intelligence (AI) in preventing obesity, addressing a critical public health issue that affects a substantial portion of the population. With obesity rates rising alarmingly, particularly in the United States, this review synthesizes findings from 46 studies published between 2008 ...
Atefehsadat Haghighathoseini, Shuo‐yu Lin, Ge Song, Ruopeng An, Hong Xue   +4 more
wiley   +1 more source